We are united in our vision to make life better for people with cancer
AVEO, in partnership with LG Chem, is on a mission to help those with cancer move forward with treatment that is effective yet allows them to carry on with their daily lives.
Together, AVEO and LG Chem Life Sciences will:
- Extend the commercial footprint of LG Chem into the US
- Diversify and expand the combined pipeline for both companies
- Accelerate continued growth through the development and commercialization of innovative
cancer therapies
LG Chem will continue to focus on pre-clinical/early clinical trial development and pursue promising anti-cancer therapies
AVEO will oversee US late-stage clinical development, leveraging LG Chem’s resources and technology to facilitate commercialization of new anti-cancer drugs
Together, we will provide differentiated solutions to improve cancer patients’ lives
Our strategy:
Grow into a global oncology leader built on a strong portfolio foundation that provides differentiated solutions for patients’ unmet needs.
Our portfolio:
AVEO and LG Chem are working to commercialize products that can potentially change the lives of patients with cancer. Our portfolio comprises both on-market and in-development medicines in the US and globally.
Our partnerships:
Operating as an LG Chem company allows us to leverage the strengths of a global presence in the industry. Additionally, we continue to actively seek out partnerships with pharmaceutical and biotech companies who share our vision for oncology drug development.
Our people:
The AVEO leadership team is a group of experienced pharmaceutical industry leaders with a passion for oncology and a proven track record of success in bringing important therapies to the patients.
Our scientific advisors:
AVEO has brought together some of the leading experts in oncology as part of their Scientific Advisory Committee, which will be advising AVEO on clinical and business development initiatives in the oncology space.